Risperidone long-acting injectable (Teva Branded Pharmaceutical)
N/A
Report date: 2025/03/11 20:00:09
Base Information
Drug NameRisperidone long-acting injectable (Teva Branded Pharmaceutical)
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved Indications
Approved Indications in ChinaN/A
Original Approved Country/Territory
Original Approved Date2023/04/28
Country/Territory +[5]
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesTeva Branded Pharmaceutical Products R&D Inc
China Registration ClassN/A
Develop Information
Other Information
ATC CodeN/A
Related LinksN/A